2016

DEC 16  CONGRATULATIONS TO DR SAM MYERS!! He successfully passed his viva with minor revision

DEC 16  Thanks Dr Celine Cano (Newcastle University) for visiting our centre and giving a wonderful talk on the development of novel DNA-PK inhibitors.

NOV 16  Axon Medchem launches the new product eCF309. This highly selective mTOR inhibitor was discovered and has been produced for sale by our lab. Due to its high selectivity, this inhibitor has been listed in the Chemical Probes portal

OCT 16  PUBLICATION Congratulations to Belén, whose research work on Pd-activated prodrugs of the HDAC inhibitor vorinostat has just been published in JMedChem

(OPEN ACCESS). 

AUG 16  Asier is admitted as a Fellow of the Royal Society of Chemistry.

JUL 16  PUBLICATION

Review article on phenotypic drug discovery strategies with Scott Warchal and Neil Carragher, just published in Future Medicinal Chemistry

MAY 16  PUBLICATION Congratulations to Craig, whose research work on the development of novel SRC/nonABL inhibitors has just been published in JMedChem

(OPEN ACCESS). 

APR 16  Asier gives the inaugural lecture at Diverciencia 2016 in his home town Algeciras (Spain). See TV news about the lecture here. See opinion article here.

APR 16  Asier speaks about the research developed by the Innovative Therapeutics Lab at the EICC as part of the InnovationNation series. See film here.

MAR 16  HIGHLIGHT

Craig's work (eCF309: a potent, selective and cell-permeable mTOR inhibitor) is featured in the Inside Front Cover of the March Issue of MedChemComm (RSC). This is a Special Issue ("New Talent: Europe") that showcases some of the top research from emerging investigators from Europe.

MAR 16  HIGHLIGHT

Craig's work (eCF309: a potent, selective and cell-permeable mTOR inhibitor) is featured in the Inside Front Cover of the March Issue of MedChemComm (RSC). This is a Special Issue ("New Talent: Europe") that showcases some of the top research from emerging investigators from Europe.

FEB 16 Our bid, supported by collaborators Prof Neil Carragher, Dr Liz Patton, Dr Paul Brennan and Prof Hing Leung, was one of the 9 winners across the UK. EPSRC’s Chief Executive, Professor Philip Nelson, said: “These Healthcare Technologies Challenge Award winners are our future research leaders who will be instrumental in ensuring the UK can meet the 21st century healthcare needs and thrive as a healthy nation.

FEB 16  Life Sciences Minister George Freeman announces over £1M funding to our lab through the EPSRC Healthcare Technology Challenge Award.

FEB 16  The Royal Society of Edinburgh announces Asier as the recepient of the RSE/Patrick Neill Medal 2016 for his outstanding research work in biomedical technologies and innovative therapeutics through multi-disciplinary collaboration

JAN 16  PUBLICATION

Collaboration with Adam Byron and Val Brunton on resistance to HER2 targeted therapy, where they used Craig's SRC/nonABL kinase inhibitor eCF506, just published in Oncotarget (OPEN ACCESS) 

JAN 16  Research proposal in collaboration with Dr Paul Brennan and Dr Dirk Sieger awarded CRUK Pioneer Award

JAN 16  Craig's MedChemComm paper selected HOT Article of 2016

2015

DEC 15  PUBLICATION Congratulations to Craig, whose research work on mTOR inhibitors has just been published in MedChemComm

(OPEN ACCESS). The article is published as part of the themed collection "New Talent: Europe"

DEC 15  Asier speaks about the bioorthogonal activation of anticancer glycosides at PACIFICHEM 2015 (Honolulu, USA)

NOV 15  PUBLICATION Congratulations to Sam, whose review on AXL inhibitors has been published in the Journal of Medicinal Chemistry

(OPEN ACCESS)

AUG 15  Asier presents the last research of the lab at the 250th ACS National Meeting & Exposition (Boston, USA)

JUL 15  CONGRATULATIONS TO DR CRAIG FRASER!! He successfully passed his viva and examiners just requested minor changes to the thesis manuscript

JUN 15  PUBLICATION

News & Views article highlighting the work reported by Vincent Rotello's lab on supramolecularly-regulated bioorthogonal catalysis and the future directions of the field published in Nat Chem

MAY 15  PUBLICATION

Collaborative work with Dr Pineda de las Infantas, Prof Molina and Dr Díaz-Mochón, from the University of Granada (Spain), identifies paradigm-changing DAPK1 inhibitors with pro-apoptotic activity. The work is published in Org Biomol Chem

APR 15  The University of Edinburgh promotes Asier to Reader in Medicinal Chemistry

MAR 15  PUBLICATION

Congratulations to Jason, whose work on bioorthogonal precursors of Floxuridine activated by Palladium chemistry (last chapter yet to be published of his thesis) has been just published in Scientific Reports

(OPEN ACCESS)

MAR 15  PUBLICATION

Collaboration with Dr Pineda de las Infantas and Dr Díaz-Mochón, from the University of Granada (Spain), on a novel synthesis of poly-substituted purines and their screening as trypanocidal agents published in Scientific Reports 

(OPEN ACCESS)

2014

NOV 14  CONGRATULATIONS TO DR JASON WEISS, who has successfully passed his viva (examiners just requested minor corrections)

JUL 14  PUBLICATION Congratulations to Jason, Craig, Belén, Sam and Richard, whose work has been published in Frontiers in Chemistry, specialty in Medicinal and Pharmaceutical Chemistry

(OPEN ACCESS)

JUN 14  Patent application US8759104B2 on biodegradable transfection reagents (licensed to Deliverics Ltd) granted in the US

JUN 14  Jason's Nat Commun paper on 5FU prodrugs activated by heterogeneous palladium catalysis featured in Synform

MAY 14  Jason's J Med Chem paper selected ACS Editor Choice

APR 14  PUBLICATION

Congratulations to Jason, whose work on bioorthogonal Palladium-activatable procursors of the nucleoside analog gemcitabine has been accepted in the Journal of Medicinal Chemistry

(OPEN ACCESS)

MAR 14  Asier's radio interview in Hoy por Hoy (Radio Algeciras Cadena Ser, Spain), where he explains (in Spanish) the recent discovery reported in Nature Communations and how this novel technology could reduce the side effects of chemotherapy

MAR 14  Jason's paper featured in C&EN and Cosmos Magazine

FEB 14  News about Jason's paper published in the press (Metro, The Scotsman, The Herald, etc.) and reported in STV Evening News

JAN 14  PUBLICATION

Congratulations to Jason, whose work on inactive 5FU prodrugs activated by Pd(0) (first ever prodrug to become activated by extracellular metal catalysis) has been just accepted in Nature Communications

(OPEN ACCESS)

2013

DEC 13  Asier is appointed Associate Editor of Frontiers in Chemistry (specialty in Medicinal and Pharmaceutical Chemistry)

JUL 13  OUR NEW LAB IN THE SECOND FLOOR OF THE EDINBURGH CANCER RESEARCH CENTRE IS READY!!!

MAY 13  Asier is elected member of the RSE Young Academy of Scotland. Established by the Royal Society of Edinburgh in 2011 is the first and (currently) only Young Academy in the United Kingdom. The Young Academy of Scotland provides a platform for abling innovative young entrepreneurs, professionals and academics to have a coherent and influential voice, and to address the most challenging issues facing society

APR 13  Asier is recognized by the Centro Andaluz de Algeciras (Spain) with the Andaluz Especial Award of 2013

2012

NOV 12  Asier is interviewed in the radio (Hoy por Hoy, Radio Algeciras Cadena Ser, Spain) and by Spanish newspaper (Europa Sur) in relation to the Young Industrialist of the Year award he received from the Royal Society of Chemistry

JUN 12  News about Nature Protocols paper published in the Daily Express

MAY 12  PUBLICATION

Investigation and first definition of BioOrthogonal OrganoMetallic (BOOM) Chemistry published in Nature Protocols

MAY 12  The Royal Society of Chemistry recognizes Asier with the RSC YOUNG INDUSTRIALIST OF THE YEAR AWARD of 2012 "for his capacity to develop and lead the translation of novel concepts into products, along with his outstanding research/commercial early track record in the chemical sciences"

FEB 12  Deliverics Ltd runner-up of New Life Sciences Company in Scotland of 2012

© 2019 by Asier Unciti-Broceta. Proudly created with Wix.com
 

  • Twitter Classic
  • Facebook Classic